Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP54943.RAFe30oFxvThWhao1uvXSV4YOOp4cBKl2r2XXgtWkW_bE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP54943.RAFe30oFxvThWhao1uvXSV4YOOp4cBKl2r2XXgtWkW_bE130_assertion type Assertion NP54943.RAFe30oFxvThWhao1uvXSV4YOOp4cBKl2r2XXgtWkW_bE130_head.
- NP54943.RAFe30oFxvThWhao1uvXSV4YOOp4cBKl2r2XXgtWkW_bE130_assertion description "[The aim of the study was to evaluate the effect of MAOB and COMT genetic polymorphism on effective daily dose of levodopa applied during the first 5 years of treatment, and to find out if a relationship exists between MAOB and COMT haplotypes and motor disturbances onset in PD patients treated with levodopa preparations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP54943.RAFe30oFxvThWhao1uvXSV4YOOp4cBKl2r2XXgtWkW_bE130_provenance.
- NP54943.RAFe30oFxvThWhao1uvXSV4YOOp4cBKl2r2XXgtWkW_bE130_assertion evidence source_evidence_literature NP54943.RAFe30oFxvThWhao1uvXSV4YOOp4cBKl2r2XXgtWkW_bE130_provenance.
- NP54943.RAFe30oFxvThWhao1uvXSV4YOOp4cBKl2r2XXgtWkW_bE130_assertion SIO_000772 15355491 NP54943.RAFe30oFxvThWhao1uvXSV4YOOp4cBKl2r2XXgtWkW_bE130_provenance.
- NP54943.RAFe30oFxvThWhao1uvXSV4YOOp4cBKl2r2XXgtWkW_bE130_assertion wasDerivedFrom gad-20130706 NP54943.RAFe30oFxvThWhao1uvXSV4YOOp4cBKl2r2XXgtWkW_bE130_provenance.
- NP54943.RAFe30oFxvThWhao1uvXSV4YOOp4cBKl2r2XXgtWkW_bE130_assertion wasGeneratedBy ECO_0000203 NP54943.RAFe30oFxvThWhao1uvXSV4YOOp4cBKl2r2XXgtWkW_bE130_provenance.